A detailed history of Foresight Capital Management Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Foresight Capital Management Advisors, Inc. holds 982 shares of AMGN stock, worth $313,542. This represents 0.19% of its overall portfolio holdings.

Number of Shares
982
Previous 932 5.36%
Holding current value
$313,542
Previous $291,000 8.59%
% of portfolio
0.19%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$309.38 - $337.38 $15,469 - $16,869
50 Added 5.36%
982 $316,000
Q4 2023

Jan 10, 2024

BUY
$255.7 - $288.46 $238,312 - $268,844
932 New
932 $268,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Foresight Capital Management Advisors, Inc. Portfolio

Follow Foresight Capital Management Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresight Capital Management Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Foresight Capital Management Advisors, Inc. with notifications on news.